Dr Thomas Park is a neuroscientist specialising in brain tumour research. His team at the Centre for Brain Research, University of Auckland, investigates brain tumour biology using brain tumour tissues and cells donated from neurosurgery. He collaborates with a wide range of clinical and scientific experts to work on project involving, 1) brain tumour drug development, 2) personalised digital diagnostics, 3) radiation neuro-biology, and 4) establishing a national brain tumour registry.

Dr Catherine Han is a New Zealand-trained medical oncologist specialising in neuro-oncology, gastrointestinal, breast, head and neck cancers, and ocular melanoma. As co-chair (clinical) and treasurer of NANOS, she played a pivotal role in its establishment in 2023. Through a Health Research Council of New Zealand (HRC) Clinical Research Training Fellowship, she pursued a PhD degree and clinical research training. Furthering her expertise in neuro-oncology, she underwent specialised training at Massachusetts General Hospital of Harvard Medical School in 2016. Currently, Dr Han serves as a consultant medical oncologist and co-director at Auckland Oncology, while also holding a Senior Lecturer position at the University of Auckland. She actively contributes to the Auckland Medical School and conducts clinical trials through the University of Auckland and New Zealand Clinical Research. Dr Han is an Executive Board member of the Asian Societies of Neuro-Oncology (ASNO), representing New Zealand, and a member of several prominent oncology societies worldwide.

Dr Dean Singleton is a cancer biologist based at the Auckland Cancer Society Research Centre, University of Auckland. His research focuses on IDH1 mutant glioma and the application of functional genomics to identify novel targets in this setting.

I completed my postgraduate M.Ch.Neurosurgical training from the Madras Medical College, University of Madras in 1992 and then went on to the Republic of Ireland and the United Kingdom, where I further completed my FRCS (Edin) in Neurosurgery  in 2004. I was then offered the opportunity to start  the Department of Neurosurgery at the Waikato Hospital in 2006, by late Dr Balakrishnan. I obtained my FRACS in Neurosurgery in 2015. Over the last 20 years the department has grown and we are now a RACS credentialled Neurosurgical training unit. My special interests are management of trigeminal neuralgia, degenerative conditions of the cervical and lumbar spine and neurovascular and neuro-oncological conditions involving the brain and spine.  I am currently the  Clinical Surgical Supervisor for Neurosurgery.

Rebecca Lissiman is a Wellington-based Neurosurgical Clinical Nurse Specialist with a specific passion for neuro-oncology. Following her neurosurgical training in the UK, she moved to New Zealand in 2012, where she supports patients and whānau from diagnosis. Acting as a vital anchor, she brings clinical safety and continuity to complex health journeys, working closely with Brain Tumour Support NZ and the Cancer Society to champion equitable, patient-centred care.

Dr Melissa James is a radiation oncologist practising in Christchurch, New Zealand. Her specialty interests lie in the use of radiation for palliation and in the treatment of breast cancer, brain tumours and melanoma. Her current focus is advocating for adequate workforce and facilities to improve access to radiation treatment within New Zealand. She has been involved with teaching and training registrars and is passionate about training the new generation of radiation oncologists. She is also passionate about improving patient outcomes and has been involved in the introduction of new technology to improve radiation techniques for brain tumour patients.

Holly Wilson is a neuroscientist based at the Centre for Brain Research, University of Auckland. She is the national coordinator for the New Zealand Brain Tumour Registry project, involving collaboration with patients, scientists, clinicians, and government agencies across the country. She has a special interest in paediatric neuro-oncology, neurosurgery, and health policy, and is passionate about leading improvements in patient care at the national level.